Hidden antibiotics: Where to uncover?

Area of Science:

• Microbiology
• Drug Discovery
• Biotechnology

Background:

• The rise of antibiotic resistance in pathogens is diminishing the effectiveness of existing treatments.
• There is a critical need for novel antibacterial agents, particularly against Gram-negative bacteria.
• Discovering new antibiotics is challenging and slow, demanding innovative solutions.

Purpose of the Study:

• To explore novel strategies for identifying natural product-based antibacterial compounds.
• To assess the potential of synthetic biology in addressing the antibiotic discovery challenge.
• To evaluate alternative therapeutic approaches like narrow-spectrum antibiotics and phage therapy.

Main Methods:

• Review of current literature on natural product discovery for antibacterials.
• Analysis of synthetic biology applications in drug development.
• Discussion of emerging therapeutic modalities and their readiness for clinical transition.

Main Results:

• Natural products remain a promising source for novel antibacterial scaffolds.
• Synthetic biology offers tools to enhance the discovery and production of potential drug candidates.
• Phage therapy and narrow-spectrum antibiotics represent viable alternatives to traditional antibiotics.

Conclusions:

• A multi-pronged approach combining natural product exploration, synthetic biology, and alternative therapies is crucial.
• Technological advancements are essential to overcome the antibiotic resistance crisis.
• Transitioning to diverse therapeutic strategies is necessary for future infectious disease management.